Members of the apolipoprotein gene cluster (APOA1/C3/A4/A5) on human chromosome 11q23 play an important role in lipid metabolism. Polymorphisms in both APOA5 and APOC3 are strongly associated with plasma triglyceride concentrations. The close genomic locations of these two genes as well as their functional similarity have hindered efforts to define whether each gene independently influences human triglyceride concentrations. In this study, we examined the linkage disequilibrium and haplotype structure of 49 SNPs in a 150-kb region spanning the gene cluster. We identified a total of five common APOA5 haplotypes with a frequency of greater than 8% in samples of northern European origin. The APOA5 haplotype block did not extend past the 7 SNPs in the gene and was separated from the other apolipoprotein gene in the cluster by a region of significantly increased recombination. Furthermore, one previously identified triglyceride risk haplotype of APOA5 (APOA5*3) showed no association with three APOC3 SNPs previously associated with triglyceride concentrations, in contrast to the other risk haplotype (APOA5*2), which was associated with all three minor APOC3 SNP alleles. These results highlight the complex genetic relationship between APOA5 and APOC3 and support the notion that APOA5 represents an independent risk gene affecting plasma triglyceride concentrations in humans.
in APOA1 primarily affect HDL-cholesterol cocentrations, while variation in APOC3 is primarily associated with altered plasma triglyceride concentrations. In APOC3, two rare alleles in the promoter region (−482C →T and −455T →C) and a minor allele in the 3′UTR (SstI polymorphism, 3238G →C) have repeatedly been associated with elevated plasma triglyceride concentrations in several human populations [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . However, the lack of strong functional data at least for the SstI polymorphism raises questions whether the association seen in humans is due to these sequence variants in APOC3 directly or due to other functional variants in APOC3 or possibly in one of the neighboring apolipoprotein genes.
Recently, we identified a fourth member (APOA5) of the chromosome 11 apolipoprotein gene cluster, located approximately 27 kb distal to APOA4 and 37 kb from APOC3 [1] . Similar to APOC3, APOA5 has been shown to be involved in plasma triglyceride level regulation in both humans and mice. Mice overexpressing human APOA5 have decreased plasma triglyceride concentrations, while mice lacking apoA5 have increased plasma concentrations of triglycerides [1] . Similarly, initial studies in humans showed that three single-nucleotide polymorhisms (SNPs 1-3) in and around APOA5 were significantly associated with altered plasma triglyceride concentrations in two human populations [1] . A fourth SNP (called SNP 4), located between APOA5 and the proximal APOA4 gene, was not associated with any plasma lipid measures. Additional association analysis of the APOC3 SstI polymorphism in this population revealed no association with triglycerides. This results suggested that the association found with APOA5 sequence variants was independent of the previously reported effect of the APOC3 SstI polymorphism on plasma triglyceride concentrations. The association of APOA5 has been confirmed in other studies [16] [17] [18] [19] . In our subsequent analysis of multiple ethnic groups, we identified additional sequence variants in and around APOA5 and described two haplotypes that were independently associated with increased plasma triglyceride concentrations in Caucasians, African-Americans, and Hispanics [20] . Between 25 and 50% of individuals in these populations carry at least one of the two risk haplotypes, designated APOA5*2 and APOA5*3.
Despite these results, questions remain about the relationship between APOA5 and APOC3 sequence variants and plasma triglyceride concentrations. Other than the initial results showing no association of SNP 4 (located between APOA5 and APOC3) and SstI in APOC3 with plasma triglyceride concentrations in a single population [1] , no data are available about the linkage disequilibrium (LD) structure or haplotype patterns between APOA5 and APOC3. The purpose of this study was to analyze comprehensively sequence variants across the entire apolipoprotein gene cluster and adjacent regions and to determine the LD and haplotype structure of the region to assess any potential relationship between APOA5 and APOC3 haplotypes and their individual alleles. The data we present support that the APOA5 locus is separated from the other apolipoprotein genes by a region of increased recombination. Of all haplotypes across APOA5, only one haplotype (APOA5*2) is significantly associated with the minor alleles of the APOC3 SstI (3238G →C) and the two promoter polymorphisms (−482C →T and −455T →C), indicating a complex and intricate relationship between different haplotypes across this gene cluster on human chromosome 11. In contrast, the second risk haplotype (APOA5*3) is not associated with other haplotypes or alleles in the neighboring apolipoprotein genes, thus establishing that APOA5 independently contributes to interindividual differences in plasma triglyceride concentrations in humans.
Results

SNP genotyping
For our analysis of linkage disequilibrium and haplotype structure, we identified 67 SNPs in the APOA1/C3/A4/A5 region from our resequencing efforts, published reports, and public databases (dbSNP). SNPs were genotyped in individuals from 10 independent three-generation CEPH families from Utah and included all four grandparents, both parents, and two children (one boy and one girl). After removing SNPs that were not polymorphic in our sample or were not in Hardy-Weinberg equilibrium, we analyzed 49 SNPs that spanned a total of approximately 152 kb of sequence on human chromosome 11q23, resulting in an average distance of 3112 bp between neighboring SNPs. Almost 82 kb of sequence distal to APOA5 and over 60 kb of sequence proximal to APOA5 were investigated. Within the APOA5 gene (SNPs 17-23), the average distance between SNPs was 504 bp, spanning at total of 3021 bp. The flanking regions including the APOA4/C3/A1 gene cluster had an average distance of 3620 bp between SNPs. Sixteen SNPs were located distal to APOA5, 26 SNPs were located proximal. Previous studies reported that LD between SNPs in different regions of the human genome extended over a range of 6-110 kb [21] [22] [23] , therefore we selected a high SNP density for our study (1 SNP per 3-4 kb) to ensure our ability to detect any LD between neighboring SNPs. A complete list of all SNPs used for the analysis can be found in Table 1 . The approximate location of all SNPs relative to the genes in this interval is depicted in Fig. 1 .
Analysis of linkage disequilibrium across the apolipoprotein gene cluster
To determine the extent of LD in our samples, |D′| was calculated for all pairs of SNPs according to Lewontin [24] . Only phased data from unrelated individuals were included in the calculations. Data included all grandparental haplotypes of the CEPH families (a total of 80 independent chromosomes), which were determined from genotyping data of the threegeneration families using GENEHUNTER [25] . A schematic diagram of all pairwise comparisons between the SNPs in the region based on the CEPH samples is shown in Fig. 2 . As is evident from the graphic, there is significant LD between large numbers of SNPs. Sixtyfour percent of all pairwise |D′| values equal 1, the maximum possible value, indicating complete LD between the two SNPs. Sixty-four percent of all pairwise |D′| values are greater than 0.8. If only SNPs with a minor allele frequency greater than 10% are considered for these pairwise calculations, 18% of pairwise |D′| values are 1, and 31% are greater than 0.8. Despite the extensive LD across the region, the pattern is disrupted by several neighboring SNPs with low LD (e.g., SNPs 29-32, see Fig. 2 ).
Haplotype structure of APOA5
Initially, we examined the haplotypes present in our sample across the APOA5 gene locus. Seven SNPs (SNPs 17-23) around the gene that were included in the haplotype analysis are in complete linkage disequilibrium. These SNPs span 3021 bp and include the entire coding region of APOA5. The locations of all SNPs in this block and the observed haplotypes are illustrated in Fig. 3 . In our CEPH sample set, only two haplotypes have a frequency over 10%, one consisting of the major allele for all seven SNPs and the other including the minor allele of SNP 18. The two previously described triglyceride-risk haplotypes (APOA5*2 and APOA5*3) as well as another haplotype involving the minor allele of a nonsynonymous SNP (SNP 19) are found in only 3 of the 80 chromosomes (3.8%).
Relationship of APOA5 haplotypes to APOC3 polymorphisms
Next, we examined the relationship between APOA5 haplotypes and the three polymorphisms in APOC3 (SstI (3238G →C, SNP 41), −482C →T, and −455T →C (SNPs 38 and 39)). Since these SNPs have been shown to be associated with plasma triglyceride concentrations, we tried to determine whether the previously identified triglyceride risk haplotypes for APOA5 or any other haplotypes in the APOA5 region preferentially cosegregate with either allele of these three APOC3 polymorphisms. The results of our analysis are presented in Table 2 . The haplotype APOA5*2 is strongly associated with the minor alleles for all three APOC3 polymorphisms. Eighty-five percent of chromosomes with APOA5*2 contained the minor allele for SstI. In contrast, the other previously identified risk haplotype, APOA5*3, showed no significant association with the three minor APOC3 alleles. Only one haplotype with a frequency of greater than 10% that spans all SNPs from APOA5 to APOC3 (SNPs 17-41) can be identified. In this haplotype, every SNP is represented by the common allele (data not shown). This analysis of the relationship of APOA5 risk haplotypes and SNP alleles in and around APOC3 suggests that the APOA5*3 haplotype exerts its effect on triglycerides independent of SstI and the two promoter polymorphisms.
Analysis of recombination by the four-gamete test
If two neighboring SNPs occurred through single mutation events in human history, one would expect to see only three of four possible allele combinations in the gametes in the absence of recombination between the two SNPs. Therefore, the four-gamete test [26] has traditionally been used as a measure of evidence of recombination. However, the presence of a fourth gamete could also be caused by gene conversion or multiple recurring mutations at the site. Thus, the test has been used in other studies primarily as supporting evidence for recombination or disruption in LD between SNPs [27] .
As shown in Fig. 4 , the results of the four-gamete test for our CEPH sample revealed results similar to those of the LD analysis ( Fig. 2) . At several sites between APOA5 and APOC3, a fourth gamete type can be found in this small sample, suggesting that recombination may have contributed to the breakdown in continuous LD between the two genes. As a consequence, APOA5 (SNPs 17-23) and APOC3 (SNPs 38-41) do not reside in the same continuous genomic region uninterrupted by recombination.
Haplotype block structure and recombination in the apolipoprotein gene cluster region
Previous studies have suggested that historic recombination events result in complex patterns of haplotype blocks across genomic regions. To support our results of the LD and four-gamete test analyses that suggested a separation of the APOA5 and APOC3 loci, we used a simplified approach to defining adjacent haplotype blocks. Our main emphasis was to determine whether there was any evidence for a haplotype block extending from APOA5 to APOC3. Our analyses using |D′| and the four-gamete test had already suggested that the two gene regions had been separated by historical recombination events. Therefore, we used a haplotype block-based analysis approach to gather additional evidence for increased recombination in the region between APOA5 and APOC3 compared to the remainder of the investigated genomic interval. Haplotype blocks were defined as contiguous sets of neighboring SNPs in which 90% of all chromosomes in the sample were represented by the four most common haplotypes for the given set of SNPs (block definition 1). The definition was based on the observation in previous studies that within haplotype blocks, 80-90% of all chromosomes were represented by the three or four most common haplotypes for that block [22, [28] [29] [30] . For our analysis, the first block was defined around APOA5, and the size of the block was maximized using the block definition. Subsequently, the neighboring haplotype blocks were determined using the same block criteria, starting from the first two SNPs adjacent to the initial APOA5 block and adding one additional SNP at a time. A representative diagram of the resulting haplotype blocks and all represented haplotypes in each block is shown in Fig. 5 . A total of nine blocks covered the entire flanking region. No block included both APOA5 and APOC3 (SNPs 17-41). The average size of each block was 4.7 SNPs (3-7 SNPs), covering on average 13,299 bp (6343-32,111 bp).
To explore the effect of the block definition parameters on the block boundaries, we repeated the analysis on the same CEPH dataset with a different haplotype block definition in which 80% of all chromosomes were represented by the three most common haplotypes (block definition 2). With this block definition, a total of eight blocks were defined for the flanking region, containing on average 5.7 SNPs (3-9 SNPs) and covering 12,535 bp (6207-37,968 bp).
Again, no block included both APOA5 and APOC3. The block boundaries based on the two different block definitions coincided only for the blocks immediately adjacent to the APOA5 haplotype block. With increasing distance from APOA5, the blocks overlapped significantly for the majority of SNPs (>70%), but not entirely.
To verify that no continuous haplotype block that includes both APOA5 and APOC3 exists, we used the haplotype definition used by Gabriel et al. [29] , which is based on measures of LD across the region. As with our analysis, no single haplotype block can be identified that spans both genes (data not shown). The same result is obtained when the HaploBlockFinder [31] is used. This approach, based on the greedy algorithm used by Patil et al. [28] , also divides the entire dataset into sets of consecutive haplotype blocks. As in our approach, APOA5 SNPs are always grouped in one block, regardless of the parameters used, and this region is separated from the APOC3 region by several interspersed small haplotype blocks (data not shown).
Next, we attempted to identify regions where recombination was increased between haplotype blocks. If such a region separated APOA5 from any or all of the other apolipoprotein genes, it would be highly unlikely that any association seen with an APOA5 haplotype could be caused by a SNP or haplotype at one of the other genes.
If no recombination had occurred between adjacent haplotype blocks, it would be predicted that in every sample tested, a haplotype in one block would be paired with just one specific haplotype in the adjacent block. In reality, however, all samples having a specific haplotype in one block do usually continue with more than just one haplotype in the neighboring block. This often results in a large number of observed haplotype combinations across block boundaries. The more different haplotype combinations one would find, the higher would be the number of necessary recombination events that "mixed" the ancestral haplotypes between the two blocks.
To use this metric in our analysis, we determined the total number of "links" between all haplotypes of adjacent blocks (i.e., the total number of combinations of haplotypes from two adjacent blocks that were found in our sample set). These links are illustrated by lines in Fig.  5 . We then determined the minimum number of links needed to connect each haplotype to at least one haplotype in the adjacent block (the set of links one would expect without any recombination). The difference between these two numbers represents the "excess" combinations, i.e., the number of combinations of haplotypes from adjacent blocks that arose through recombination of the ones included in the set of "minimum" combinations. We calculated the percentage of excess combinations and also the percentage of samples represented by these excess combinations between haplotype blocks.
For the CEPH haplotypes, the greatest number of samples represented by excess haplotype combinations across block boundaries could be found between SNPs 23 and 25 (22% of all samples), immediately adjacent to the APOA5 gene. This was significantly different from the average of all other regions (p < 0.01). The greatest percentage of excess connections was found across the block boundary between SNP 27 and SNP 31. Almost half (49%) of the connections represented excess connections between adjacent blocks. Again, this percentage was significantly different from the average for all other block boundaries (25%, p < 0.01). Both statistical analyses identified the region adjacent to APOA5 as a region of significantly increased recombination and therefore clearly separated haplotypes of APOA5 from APOC3 and the other apolipoprotein genes. This evidence for increased recombination between the two genes explains the lack of a contiguous haplotype block that spans both genes in our sample set.
Discussion
The two apolipoprotein genes APOA5 and APOC3 have repeatedly been reported to affect plasma triglyceride concentrations in humans and in mouse models. For both genes, common genetic variants that are strongly associated with alterations in human plasma lipid concentrations have been identified. Despite these results, the correlation between the two genes is not clear, and questions remain about the relationship of the SNPs in these two neighboring genes. It is possible that the association seen with SNPs in one of the two genes might be due to a causative SNP located in the other gene that is in strong LD. If this were true, one would expect to find either a single haplotype block spanning both genes or two distant haplotypes that are in strong LD. Our analysis of LD between SNPs and their resulting haplotype patterns indicates that no continuous haplotype block that would link APOA5 and APOC3 exists. Furthermore, we identify a region of significantly increased recombination separating the two genes, suggesting that the observed association of APOA5 variants on plasma triglyceride concentrations is independent of APOC3.
Traditionally, studies investigating LD between SNPs have relied on SNPs discovered through resequencing efforts. However, recent studies have shown that public databases contain over 50% of all SNPs with a frequency >10% in the human genome [32] . Therefore, we utilized this resource in our studies and selected SNPs from public databases. Special additional emphasis was given to SNPs that were previously reported in association studies across the gene cluster region. While we did not utilize every common SNP in the region, the high degree of LD observed between adjacent SNPs makes it likely that additional SNPs located between the SNPs used in the study would also be in LD and therefore be represented by the same haplotypes. This can be illustrated by the fact that the three most common haplotypes of APOA5 can be unambiguously identified using only publicly available SNPs and ignoring SNPs discovered by our resequencing efforts.
Our results of linkage disequilibrium from pairwise analysis of SNPs across the gene cluster region show significant allelic association across the entire cluster in the CEPH sample of individuals of Northern European descent, but the LD structure is complex, and no clear blocks are evident. While several sets of neighboring SNPs are in significant LD with each other, the results do not resolve the question whether there is strong LD between variants in APOA5 and APOC3. Individual APOA5 SNPs show strong LD to APOC3, but the two genes seem to be separated by a region of low LD (SNPs 29-32, see Fig. 2 ). The detection of high overall levels of LD (60% of pairwise |D′| = 1) may be partly due to low minor allele frequencies for several of the SNPs used in the analysis. Low minor allele frequencies for one or both SNPs artificially inflate |D′| and increase the probability of |D′| = 1. Nevertheless, when only SNPs with a minor allele frequency greater than 10% are used, approximately one-third of all pairwise comparisons still detect significant LD (|D′| > 0.8) in the CEPH sample. This illustrates the high overall degree of LD across the entire gene cluster region. Despite the high overall LD, APOA5 is still separated from the adjacent apolipoprotein genes by a region of low LD, suggesting increased recombination between APOA5 and the APOA4/C3/A1 cluster. This is supported by the results of the four-gamete test. Several pairs of adjacent SNPs between APOA5 and the APOA4/C3/A1 cluster show all four possible combinations of SNP alleles, suggesting recombination events mixing the ancestral alleles. While the occurrence of all four gamete types is not unambiguous proof of recombination (four gametes could also be observed in the case of recurring mutation events or gene conversion), results from the LD analysis and the four-gamete test support the hypothesis of increased recombination in the region between APOA5 and APOC3.
To test this hypothesis further, as well as to analyze the haplotype block structure reflecting the complex LD patterns across the entire region, we defined haplotype blocks as areas with limited haplotype diversity within each block. The definitions of a haplotype block in our analysis were based on previous haplotype analyses by other groups. Most studies reported that within haplotype blocks, 80-90% of the chromosomes are represented by three or four common haplotypes [22, [28] [29] [30] . Accordingly, we defined haplotype blocks as contiguous sets of neighboring SNPs where 90% of all chromosomes in the sample were represented by the four most common haplotypes for the given set of SNPs (block definition 1) or 80% of the chromosomes were represented by the three most common haplotypes (block definition 2). Currently, there is extensive debate about the best approach for defining haplotype blocks in the human genome. Large-scale efforts (HapMap Project) are under way to generate comprehensive data about these blocks for the entire human genome. However, no single approach has been proposed and accepted for the analysis of these data at this point. Different studies have based their block definitions either exclusively on the degree of LD detected in that region or on a balanced approach to minimize the number of SNPs needed to differentiate all major haplotypes [33] . The resulting haplotype blocks either are contiguously subdividing the region into blocks of different size [28] or identify localized blocks of high LD [29] . Discussions have been focusing on the biological usefulness of different definitions and the usefulness of the resulting partitioning for disease association studies [34, 35] . In our studies, we defined haplotype blocks exclusively for the purpose of examining and detecting possible recombination events. In addition, we tried to assess whether specific SNPs can always be found in one haplotype block regardless of the parameters used to define them.
With the two definitions used in our analysis, we find no continuous haplotype block that includes both the APOA5 and APOC3 gene regions. The resulting individual blocks are relatively short (approximately 13 kb), and their accurate location is different depending on the block definition used. To our knowledge, no previous study examined the effect of varying definition parameters on the resulting haplotype block structure. Our data for the apolipoprotein gene cluster region indicate that blocks obtained using different definitions overlap well for regions of high linkage disequilibrium, but the boundaries shift for regions with less LD between SNPs. In this genomic region, over 70% of SNPs are assigned to blocks that are identified with both definitions, reflecting the high degree of LD in this gene cluster. Other proposed algorithms to define the haplotype block structure [28, 29] lead to the same conclusion that the APOA5 and APOC3 gene regions do not reside in the same haplotype block.
The blocks identified in our analysis were independent of the SNPs selected for analysis, their density, or their allele frequency. Analyzing fewer SNPs across the region, the exact location of haplotype block boundaries varied, but three genomic intervals were always included in haplotype blocks. One of these regions included APOA5, and the two other regions were located upstream of APOA4 and in the 3′ region of MGC13125. Similar results were obtained when only SNPs with a minor allele frequency above 10% were included in the analysis.
We would like to emphasize that the block structure defined by our analysis approach was used only to test whether APOA5 and APOC3 are located in one block. Any of a variety of other block definition algorithms yields the same result. However, we subsequently used our data for a novel approach to estimate the variation in recombination across this genomic interval to support the findings from our LD analysis and the four-gamete test. For this, we analyzed the degree of recombination found between adjacent haplotype blocks. The approach unambiguously identifies two haplotype block boundaries proximal to APOA5 that show increased recombination. The two regions, indicated in Fig. 5 by the black arrows, clearly separate APOA5 from the neighboring apolipoprotein genes. Previous studies have already estimated that the apolipoprotein gene cluster region has a fourfold higher average recombination rate than the genome-wide average [36] . However, due to the limited resolution of RFLP analysis, the exact location for this increased recombination was not identified. It is conceivable that the region between APOA5 and APOA4 is at least in part responsible for this increased overall recombination rate. This increased recombination supports that the association found between SNPs and haplotypes in APOA5 and altered plasma triglyceride concentrations is not due to linkage disequilibrium with causative APOC3 variants.
Despite the LD and haplotype evidence that separates APOA5 from the other apolipoprotein genes in the cluster, individual APOA5 haplotypes do show association with APOC3 alleles. We identified five different haplotypes for the APOA5 region in the CEPH sample. Of these, only risk haplotype APOA5*2 is significantly associated with the minor allele of the SstI polymorphism and the two promoter variants in APOC3. All other haplotypes show little or no association with the minor allele, and one haplotype is exclusively found with the common allele (S1) of SstI. This association is also evident in other populations that have been ascertained for these polymorphisms (data not shown). In another Caucasian population from the Midwest United States [37] , the frequencies of the two risk haplotypes are higher than in our CEPH sample (4.6 and 8.0% for APOA5*2 and APOA5*3, respectively). Still, APOA5*2 is clearly associated with the minor allele of SstI (72.7% of all chromosomes with the APOA5*2 risk haplotype).
Overall, this analysis confirms that the other previously identified risk haplotype (APOA5*3) shows no association with SstI or the APOC3 promoter SNPs, suggesting that the association with plasma triglycerides is likely to be independent of APOC3 or other genes in this cluster, although we could not test directly for this in our sample.
It remains to be seen whether the effect of the APOA5*2 risk haplotype is due to a functional polymorphism in APOC3 or whether the APOA5 haplotype is responsible for the association seen between the minor allele of the three APOC3 SNPs and plasma triglyceride concentrations. In addition, the relationship between the two genes should be investigated in greater detail in other ethnic groups as well, given the apparent difference in the frequency of APOA5 risk haplotypes [20] . Functional studies are under way to address this question. Our analysis clearly shows that APOA5 is an independent risk gene for elevated plasma triglyceride concentrations as evidenced by the APOA5*3 risk haplotype. Extensive functional studies will be needed to elucidate the individual contributions of SNPs within APOA5 to altered plasma triglyceride concentrations.
Materials and methods
Genotyping of single nucleotide polymorphisms
In total, 67 SNPs were selected for our analysis from a region spanning 152.5 kb around the apolipoprotein gene cluster on human chromosome 11. Of these SNPs, 7 in and around APOA5 were initially discovered by us and other collaborators by direct sequencing [1, 20] . An additional 4 SNPs in the region were discovered through resequencing, and the remaining 56 SNPs were retrieved from dbSNP and published reports. Currently, 348 SNPs are listed in dbSNP (http://www.ncbi.nlm.nih.gov/SNP/index.html) for the apolipoprotein gene cluster region. We selected all SNPs in the APOA5 region, and 1 SNP per approximately 3 kb of flanking sequence to ensure a dense map to detect LD between neighboring SNPs. In addition, we included SNPs in and around the other apolipoprotein genes that were reported previously in association studies: SNPs 34, 35, and 36 are nonsynonymous changes in APOA4; SNPs 38 (APOC3 −482), 39 (APOC3 −455), and 41 (SstI) are located in APOC3; and SNP 43 (XmnI polymorphism) is located in APOA1 (see Table 1 ).
All SNPs were genotyped using the biplex Invader assay, as previously described [38] . SNPs were genotyped on a set of 80 samples representing 10 independent three-generation CEPH families from Utah. Of the 67 SNPs, 9 SNPs (13.4%) were not polymorphic in the samples used for our study, and three assays failed. An additional 3 SNPs (4.5%) had minor allele frequencies of less than 1% in our samples, and were not included in the analysis. For all SNPs, we tested for Hardy-Weinberg equilibrium. Three SNPs significantly deviated from equilibrium and were excluded from further analysis. The remaining 49 SNPs (73.1%) were used for all subsequent analyses and are numbered in Table 1 .
Analysis of linkage disequilibrium
Genotypes obtained from the CEPH families were imported into GENEHUNTER [25] . The HAPLO program option was used to determine the grandparental haplotypes across the entire region. Less than 0.4% genotyping errors were detected, and all erroneous genotypes were repeated and unambiguously resolved. Haplotype data for all independent samples (grandparents) were used to calculate pairwise linkage disequilibrium. Lewontin's parameter of LD, |D′| [24] , was calculated for all pairwise comparisons.
Four-gamete test
The four-gamete test was applied to the CEPH dataset as described in previous studies [26, 27] . For any given two-SNP haplotype AB, mutation will lead to the formation of either Ab or aB. A haplotype consisting of the two alleles ab can arise only through recombination or repeated mutation. The four-gamete test essentially examines the sample set for the presence of all or a reduced number of gametic allele combinations. The test was applied as implemented in the software program DnaSP 3.51 [39] .
Analysis of the haplotype block structure
To define haplotype blocks, the region in and around APOA5 was investigated first. SNPs 17-23 were defined as the starting block for our algorithm using MATLAB. Haplotype blocks were defined as regions where at least 90% of all haplotypes were represented by the four most common haplotypes. Alternatively, the definitions were changed so that 80% of all haplotypes were represented by the three most common haplotypes. In the first iteration, the initial block of SNPs 17-23 was expanded by adding 1 neighboring SNP at a time from either the 3′ or the 5′ end to maximize the size of the region. Once the maximal block size around APOA5 was determined, the algorithm was started again to determine blocks in the neighboring SNPs. Here, the algorithm started with the first 2 SNPs outside the initial APOA5 block and then added the third SNP and tested whether the haplotype block definition was still fulfilled. If the four major 3-SNP haplotypes still represented more than 90% of all chromosomes in the sample, the next SNP was added. The iterations stopped once the haplotype definition criteria were no longer met. The last set of SNPs fulfilling the conditions was defined as a new haplotype block, and the algorithm was restarted using the first 2 SNPs outside the newly defined block. Haplotype blocks were defined using the complete set of 49 SNPs, a set of SNPs comprising all SNPs in the initial APOA5 haplotype block and all SNPs in the flanking regions with minor allele frequencies above 10%, and finally a set of SNPs consisting of the APOA5 SNPs and only every second SNP in the flanking regions. These two modified datasets were used to determine the effects of allele frequencies and SNP density on the definition of haplotype blocks and their boundaries in our sample.
Analysis of recombination
Based on the haplotype block structure determined as described above, we counted all combinations of haplotypes across each boundary that could be found in our sample. Each combination is represented by a line in Fig. 4 . We counted the total number of lines for each boundary. Then we determined the minimum number of combinations needed to connect each haplotype in one block with at least one haplotype in the other block. These lines represent the minimum number of combinations needed to explain the observed data. With only these combinations of haplotypes, the sample set would still have all haplotypes for both blocks represented. Any additional connections found in the sample would have arisen through recombination between any of these "essential" haplotype combinations. Next we proceeded to count the additional (excess) combinations of haplotypes found in our sample and the number of chromosomes with these combinations. Calculating the ratio of these additional lines to the total number of lines (i.e., percentage excess connections between haplotype blocks) and determining the percentage of samples that are represented by these excess connections give a measure of recombination between the two blocks. Due to the non-normality of the data, the significance of difference in the dataset was assessed using nonparametric tests (Wilcoxon, Median, Kolmogorov-Smirnov).
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Fig. 1.
Diagram of the apolipoprotein gene cluster region on human chromosome 11q23. All genes in this region are depicted by horizontal block arrows. Apolipoprotein genes are highlighted in white and all gene names are given below the arrows. The approximate location of each SNP is indicated by the vertical arrows. Numbers correspond to the SNP numbering in Table 1 . Pairwise linkage disequilibrium. Pairwise LD was calculated according to Lewontin [24] . |D ′|, the normalized LD measure, is depicted for all pairwise comparisons. |D′| values of 1 are indicated by black squares, white squares indicate |D′| values of less than 0.5. The approximate location of SNPs is shown by the lines connecting individual rows and columns to the diagram of the genomic region. SNPs used for analysis Listed are the number of the SNP when used in the LD and haplotype analysis (first column), the position of each SNP based on the Golden Path genome annotation (human assembly November 2002), the dbSNP reference number, the minor allele frequency (MAF), and other names that were used to describe the SNP, as well as the source of the SNP information. Table 2 Association of APOA5 haplotypes with APOC3 polymorphisms Listed are the APOA5 haplotypes found in our populations. "1" indicates the major allele of the SNP, "2" indicates the minor allele of the SNP. Haplotypes are listed in order from SNP 17 through 23. Haplotype frequencies are given for both samples, and the number of chromosomes carrying each of the alleles of the three APOC3 polymorphisms is listed for each APOA5 haplotype.
